… Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for
hospitalized COVID-19 patients with moderate disease compared with standard care: a single-…

… Furthermore, we only included clinical trials that compared the clinical efficacy and safety
of sofosbuvir-based treatment with other comparators for treating patients with COVID-19. …

… COVID-19 but large clinical studies are required to confirm the idea (10, 13-15). In this study,
efficacy … SOF/LDP were assessed in treatment of patients with mild to moderate COVID-19. …

… that sofosbuvir might be a potential option to improve care of patients with COVID-19 especially
at … Efficacy and safety of sofosbuvir in treatment of COVID-19 may be considered in future …

… approved for coronavirus disease-2019 (COVID-19) infections… the efficacy and safety of
sofosbuvir (SOF) plus daclatasvir (… with moderate and severe COVID-19 infection. Multicentre …

… Furthermore, antiviral treatment in our study has been used in COVID-19 patients with early
… the same efficacy is maintained even in patients with advanced/severe COVID-19 disease, …

… the efficacy of sofosbuvir and daclatasvir with ribavirin for treating patients with COVID-19. …
To our knowledge, this is the first clinical trial of sofosbuvir/daclatasvir/ribavirin in COVID-19 …

… Sofosbuvir/ledipasvir is an approved drug to treat HCV infection. This study investigates the
efficacy of Sofosbuvir/ledipasvir as a treatment for patients with moderate COVID-19 infection…

… inhibit two coronavirus enzymes. … efficacy of the sofosbuvir/velpatasvir combination plus
the national standard of care in adult patients hospitalized with moderate to severe COVID-19 …

… suggests a potential role for sofosbuvir/ daclatasvir in treating COVID19. We aim to evaluate
the efficacy of generic sofosbuvir/daclatasvir in treating COVID-19 patients with pneumonia. …